Home Medicine A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
Article
Licensed
Unlicensed Requires Authentication

A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism

  • Chun Lin Wang , Zhu Wei Fen and Li Liang EMAIL logo
Published/Copyright: November 7, 2013

Abstract

We report the case of a 12-year-old boy with a de novo mutation in the DAX1 gene (for dosage-sensitive sex reversal, congenital adrenal hypoplasia critical region on the X chromosome, gene 1; also called NROB1). He was born at term, Addison’s disease was diagnosed at 8 years with a salt-wasting syndrome, and then hydrocortisone substitution was taken; the child continued to develop normally. A reoccurrence of salt-wasting syndrome usually happened after an episode of an abrupt withdrawal of hydrocortisone substitution. Because of adrenal insufficiency without hypogonadotropic hypogonadism, he came to the clinic at 12 years of age and hypoplasia of adrenal glands was found by MRI scans. We proposed the diagnosis of congenital adrenal hypoplasia in this patient and identified a hemizygous mutation (c.999_1000insCTCA, p.Leu335ThrfsX389) in exon 1 of the DAX1 gene. To our knowledge, it is a de novo mutation that leads to a frame-shift, a premature stop codon. In conclusion, it is very important to identify mutation in the DAX1 gene for a boy with adrenal insufficiency of unknown etiology.


Corresponding author: Li Liang, Department of Pediatrics, The First Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China, Fax: +86-571-87235128, E-mail:

Acknowledgments

We thank the children and their parents for participating in this research project. This work was supported by the Zhejiang Provincial Natural Science Foundation of China (Y2090137) and Project 81100552, supported by the National Natural Science Foundation of China and partly by the Program for Zhejiang Leading Team of Science and Technology Innovation (2010R50050).

Conflict of interest statement: The authors have nothing to disclose.

References

1. Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, et al. X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. J Clin Endocrinol Metab 2009;94:4086–93.Search in Google Scholar

2. Ostermann S, Salvi R, Lang-Muritano M, Voirol MJ, Puttinger R, et al. Importance of genetic diagnosis of DAX-1 deficiency: example from a large, multigenerational family. Horm Res 2006;65:163–8.Search in Google Scholar

3. Jadhav U, Harris RM, Jameson JL. Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol 2011;346:65–73. doi: S0303-7207(11)00225-5; pii: 10.1016/j.mce.2011.04.017.Search in Google Scholar

4. Lumaka A, Mubungu G, Nsibu C, Tady BP, Lukusa T, et al. X-linked adrenal hypoplasia congenita: a novel DAX1 missense mutation and challenges for clinical diagnosis in Africa. Eur J Pediatr 2012;171:267–70.Search in Google Scholar

5. Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672–6.Search in Google Scholar

6. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635–41.Search in Google Scholar

7. Bernard P, Ludbrook L, Queipo G, Dinulos MB, Kletter GB, et al. A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female. Mol Genet Metab 2006;88:272–9.Search in Google Scholar

8. Verrijn Stuart AA, Ozisik G, de Vroede MA, Giltay JC, Sinke RJ, et al. An amino-terminal DAX1 (NROB1) missense mutation associated with isolated mineralocorticoid deficiency. J Clin Endocrinol Metab 2007;92:755–61.Search in Google Scholar

9. Zhou J, Oakley RH, Cidlowski JA. DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner. Mol Endocrinol 2008;22:1521–34.Search in Google Scholar

10. Krone N, Riepe FG, Dorr HG, Morlot M, Rudorff KH, et al. Thirteen novel mutations in the NR0B1 (DAX1) gene as cause of adrenal hypoplasia congenita. Hum Mutat 2005;25:502–3.Search in Google Scholar

11. Li N, Liu R, Zhang H, Yang J, Sun S, et al. Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia. J Clin Endocrinol Metab 2010;95:E104–11.Search in Google Scholar

12. Wu CM, Zhang HB, Zhou Q, Wan L, Jin J, et al. Two novel DAX1 gene mutations in Chinese patients with X-linked adrenal hypoplasia congenita: clinical, hormonal and genetic analysis. J Endocrinol Invest 2011;34:e235–9Search in Google Scholar

13. Guoying C, Zhiya D, Wei W, Na L, Xiaoying L, et al. The analysis of clinical manifestations and genetic mutations in Chinese boys with primary adrenal insufficiency. J Pediatr Endocrinol Metab 2012;25:295–300.Search in Google Scholar

14. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years’ experience. J Clin Endocrinol Metab 2006;91:3048–54.Search in Google Scholar

15. Esden-Tempska Z, Lewczuk A, Tobias ES, Borozdin W, Kohlhase J, et al. Delayed diagnosis of adrenal hypoplasia congenita in a patient with a new mutation in the NR0B1 gene. J Pediatr Endocrinol Metab 2012;25:147–8.Search in Google Scholar

Received: 2013-6-23
Accepted: 2013-9-26
Published Online: 2013-11-07
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Downloaded on 20.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0260/html
Scroll to top button